Genvor Inc
No SEC Form 4 filings for $GNVR in the last 30 days.
See all $GNVR insider activity →Genvor Inc. raised $30,000 via two 6-month insider promissory notes with 15% interest and 2% original issue discount. The notes, issued to directors Dr. Jesse Jaynes and Dr. Clayton Yates, mature on April 8, 2027, and are not convertible into equity. The funds aim to bolster near-term liquidity and provide working capital, according to the company.
Genvor Inc (GNVR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On October 16, 2026, Genvor Incorporated (the “ Company ”) issued to Dr. Jesse Jaynes, a member of the Company’s Board of Directors and the Company’s Chief Scientific Officer, a promissory note (the “ Jaynes Note ”), in consi
Genvor Inc (GNVR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 3 ea029540101ex10-2.htm WARRANT DATED JUNE 17, 2026 Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning GNVR (Genvor Inc). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
The financing is small and unlikely to move the stock materially.
The notes provide short‑term financing but involve small amounts and high interest, likely exerting limited pressure on the stock.
The filing discloses dilution/financing mechanics (warrant + convertible note tranche) that can affect near-term valuation and trading risk.
AlphAI scores every news story that mentions GNVR with an AI model for sentiment and relevance, and aggregates insider trades from Genvor Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.
Genvor Inc. raised $30,000 via two 6-month insider promissory notes with 15% interest and 2% original issue discount. The notes, issued to directors Dr. Jesse Jaynes and Dr. Clayton Yates, mature on April 8, 2027, and are not convertible into equity. The funds aim to bolster near-term liquidity and provide working capital, according to the company.
1 min readGenvor Inc (GNVR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On October 16, 2026, Genvor Incorporated (the “ Company ”) issued to Dr. Jesse Jaynes, a member of the Company’s Board of Directors and the Company’s Chief Scientific Officer, a promissory note (the “ Jaynes Note ”), in consi
1 min readGenvor Inc (GNVR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 3 ea029540101ex10-2.htm WARRANT DATED JUNE 17, 2026 Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
6 min read
